American Board of Medical Quality Appoints Phytel Executive as Board Director

Dr. Richard Hodach, Phytel's Chief Medical Officer, Has Extensive Background in Automation of Care Management

DALLAS--(BUSINESS WIRE)-- Richard Hodach, MD, Chief Medical Officer of Phytel, the leader in provider-led population health improvement, has been elected to the board of directors of the American Board of Medical Quality (ABMQ). The ABMQ recognizes and certifies professionals and programs in the rapidly growing field of medical quality management.

"We are delighted that Dr. Hodach has been selected to help guide this prestigious organization," said Steve Schelhammer, CEO of Phytel. "Dr. Hodach has a long history in integrating health IT with care management and has helped build some of the leading companies in the sector. He will be an invaluable asset to the American Board of Medical Quality as it continues to refine its assessments of medical quality professionals engaged in improving care coordination and clinical processes."

Before joining Phytel, Dr. Hodach was the Senior Vice President and Chief Medical Officer of Matria Healthcare, a disease management company specializing in high-risk pregnancies. He also served as Medical Director and Vice President of Medical Affairs at Accordant, where he converted disease management programs into web-enabled disease management tools. He also co-founded MED.I.A. (Media Interactive Applications), a firm that designed and produced healthcare educational materials. Dr. Hodach, a board-certified neurologist, has a Ph.D. in pathology and electrodiagnosis, as well as a master’s degree in public health.

The goal of the American Board of Medical Quality is to promote professionally recognized and relevant credentials for physicians in the field of medical quality management. While the ABMQ is closely related to the American College of Medical Quality (ACMQ), the two organizations are separate. Whereas the ACMQ provides education in clinical quality improvement and medical quality management, the ABMQ certifies professionals in the field.

"We're pleased that Dr. Hodach has accepted our invitation to be on our board," commented Donald Fetterolf, MD, MBA, Secretary/Treasurer of the ABMQ. "His experience in the field of medical quality management and automation tools will aid the American Board of Medical Quality as we navigate the new environment of patient-centered medical homes and accountable care organizations."

About Phytel

The premier company empowering physician-led population health improvement, Phytel provides physicians with proven technology to deliver timely, coordinated care to their patients. Phytel's state-of-the-art registry, which now encompasses 20 million patients nationwide, uses evidence-based chronic and preventive care protocols to identify and notify patients due for service, while tracking compliance and measuring quality and financial results. For more information, please visit www.phytel.com. Follow us on Twitter and find us on Facebook.

About the American Board of Medical Quality

Founded in 1998, the American Board of Medical Quality evaluates and certifies professionals and programs in the field of medical quality management. Its current board of directors includes hospital quality experts, academic leaders, and health IT consultants, as well as a representative of the National Committee on Quality Assurance. For more information, please visit http://www.abmq.org/.



CONTACT:

Schwartz Communications
Davida Dinerman or Pauline Louie, 781-684-0770
[email protected]

KEYWORDS:   United States  North America  Texas

INDUSTRY KEYWORDS:   Technology  Data Management  Practice Management  Health  Hospitals  Other Health  General Health

MEDIA:

Logo
 Logo

Suggested Articles

Nearly 10,000 patients involved in research studies were impacted by a third-party privacy breach that may have exposed their medical diagnoses, test results…

Veterans Health Administration medical facilities currently have a paper medical record backlog that if stacked up would be 5.15 miles high, according to the…

The Department of Health and Human Services announced proposed changes to privacy restrictions on patients' substance use treatment records.